Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-27

Clinical Trial Update: Normobaric Oxygen (NBO) Therapy in Acute Migraine [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated normobaric oxygen therapy for acute migraine and has completed. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Normobaric oxygen therapy (oxygen)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Migraine | Phase 2 | Status: COMPLETED | Results posted: 2017-03-27